Moreover, in malignant tumours, significant insulin resistance may occur in the body, leading to abnormal transduction of plasma insulin signals related to the occurrence of malignant tumours and abnormal energy metabolism of central sensors and cells, thus inducing malignant tumours. The gene discussed is INS; the disease is cancer.